about
Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemiaPrognostic biomarkers in acute coronary syndromeMechanisms of Nuclear Export in Cancer and Resistance to ChemotherapyRole of Galectin-3 in Obesity and Impaired Glucose HomeostasisBiomarkers and severe asthma: a critical appraisalGalectin-3 as a regulator of the epithelial junction: Implications to wound repair and cancerAnti-cancer activities of pH- or heat-modified pectinGalectins and their ligands: negative regulators of anti-tumor immunityGalectin-3 in angiogenesis and metastasis.Modulation of ocular surface glycocalyx barrier function by a galectin-3 N-terminal deletion mutant and membrane-anchored synthetic glycopolymersMolecular basis for MMP9 induction and disruption of epithelial cell-cell contacts by galectin-3.An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancerMetabolism under hypoxia in Tm1 murine melanoma cells is affected by the presence of galectin-3, a metabolomics approachControl of Glycosylation-Related Genes by DNA Methylation: the Intriguing Case of the B3GALT5 Gene and Its Distinct PromotersInhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agentsA genome-wide association study of circulating galectin-3Galectin-4, a novel predictor for lymph node metastasis in lung adenocarcinomaGalectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.The role of galectin-3 and galectin-3-binding protein in venous thrombosis.Serum galectin-3 as a potential marker for gastric cancer.Glycan dependence of Galectin-3 self-association properties.Alteration of galectin-3 in tears of patients with dry eye diseaseHypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin.Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavageGalectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation.The deficiency of galectin-3 in stromal cells leads to enhanced tumor growth and bone marrow metastasis.Single Nucleotide Polymorphisms at +191 and +292 of Galectin-3 Gene (LGALS3) Related to Lower GAL-3 Serum Levels Are Associated with Frequent Respiratory Tract Infection and Vaso-Occlusive Crisis in Children with Sickle Cell Anemia.Changes in renal gene expression associated with induced ochratoxicosis in chickens: activation and deactivation of transcripts after varying durations of exposure.Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling.Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration.MicroRNA-424 Predicts a Role for β-1,4 Branched Glycosylation in Cell Cycle Progression.Phenotypic and Molecular Characterization of MCF10DCIS and SUM Breast Cancer Cell Lines.Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium.LGALS3 and AXIN1 gene variants playing role in the Wnt/ β-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancerGalectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation.Galectin-3: a possible complementary marker to the PSA blood test
P2860
Q24311970-2CE1BF6F-FCEC-4768-8B5B-05E373D22C77Q26738521-9A0A107C-BC14-45EC-BCD6-95769CF06797Q26764837-561D5DF7-78FE-4FEB-A16E-5B9E3942AD09Q26771826-BE76A46E-995F-4F70-B070-10947E1998D5Q26782718-EBAD9C9B-09D4-4614-B8C6-6D454664D89AQ26785535-BA6C5D65-CEC6-49BD-BD71-53BF40E06D7DQ26821932-D2CA7B6A-E177-4FAB-A4AE-1B9D9DFF0C67Q27024580-24A8C4FB-A106-443C-B476-F27D91D19D0DQ27687444-75790978-3640-462D-A500-5C69F48FB70DQ28535428-DA7F4F41-054D-4981-837B-641163642134Q30583539-9EE57E6B-7317-49C8-8BCD-541420A87981Q33926952-4F628B8D-23D9-4046-B147-FC048352DFC3Q34056427-23365B34-06DE-4F03-868B-AF27E08494E1Q34168148-6DA50D23-0462-4BD1-84A8-B513BAD4B91AQ34317986-A60ADAC8-DB49-4094-86C2-12A7637F5CB8Q34410193-2D9D98A9-3C40-48E4-9918-B761087D351FQ34443077-A7431EE4-4AA6-4CBE-88A0-638D17A8FAB2Q35067654-A4E84B63-7BD0-4C74-9F64-7E232AD0740BQ35096615-CC788649-DEB7-4FD2-AA5F-E21150BDC04EQ35171280-01335670-3A45-4C4D-A2F8-A118E4B0CF8EQ35207994-06F16D9A-F9E4-4C97-A8DB-054CC703407CQ35392021-7BC3B456-9AF8-4F69-845C-7EB64FA9C299Q35589468-84C3AF59-4AFA-4A89-84BB-409D36DDB961Q35723085-ADEF414E-9739-45FC-8B7A-B5119F7A3643Q35741579-D29D401A-284F-46FB-BBA9-AEC7776B0FD8Q35773875-4F62D1CE-09CC-481B-B1E6-ED577AE4B85AQ36035702-95D5A0A0-F54C-4BF8-991A-B8430352EF7DQ36101399-D3B5112C-D402-4C5F-B839-64678F9A2925Q36104317-9CE77F96-69D8-48B8-8947-F81DDCAF37B3Q36125402-ADBE3CAD-C18B-462C-AB98-CE16102E8593Q36212749-EA59679C-3BDA-443B-A6A3-510B0D1148BFQ36260595-D1BFFAB3-9E67-4228-BE6E-7B1F31208BE2Q36262236-A9BE90C5-2CB3-401F-92E2-5ECD37D928D7Q36466243-0B142900-E8D0-417E-A520-DBEBC711A745Q36582681-A36DF780-1B00-42E4-8BF3-FF05ECFC126AQ36642752-D061F2B1-A059-4141-B1C2-F11BB76C986FQ36746178-C67E08EC-4DAE-4F2D-BA00-61A916AE0334Q36857748-2D38AB61-B488-48AB-88D1-10433F64B60BQ36877769-7E9AA05C-3DF7-4D1F-9E9A-6AC87C3E4EF5Q37038393-36ACCD97-4CA7-4974-B2BE-5A8A6E4E5167
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Galectin-3--a jack-of-all-trades in cancer.
@ast
Galectin-3--a jack-of-all-trades in cancer.
@en
Galectin-3--a jack-of-all-trades in cancer.
@nl
type
label
Galectin-3--a jack-of-all-trades in cancer.
@ast
Galectin-3--a jack-of-all-trades in cancer.
@en
Galectin-3--a jack-of-all-trades in cancer.
@nl
prefLabel
Galectin-3--a jack-of-all-trades in cancer.
@ast
Galectin-3--a jack-of-all-trades in cancer.
@en
Galectin-3--a jack-of-all-trades in cancer.
@nl
P1433
P1476
Galectin-3--a jack-of-all-trades in cancer.
@en
P2093
Anna U Newlaczyl
Lu-Gang Yu
P304
P356
10.1016/J.CANLET.2011.09.003
P407
P577
2011-09-17T00:00:00Z